Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients
暂无分享,去创建一个
C. Creighton | Yiqun Zhang | D. Gibbons | J. Kurie | D. Mishra | Min P. Kim | Min P Kim
[1] Manuela Malatesta,et al. Histological and Histochemical Methods - Theory and Practice , 2016, European journal of histochemistry : EJH.
[2] Milind B. Suraokar,et al. A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients , 2013, Clinical Cancer Research.
[3] Mats Lambe,et al. Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation , 2012, Clinical Cancer Research.
[4] Michael J. Thrall,et al. Human Lung Cancer Cells Grown in an Ex Vivo 3D Lung Model Produce Matrix Metalloproteinases Not Produced in 2D Culture , 2012, PloS one.
[5] Thomas Streichert,et al. Genome-Wide Gene Expression Analysis in Cancer Cells Reveals 3D Growth to Affect ECM and Processes Associated with Cell Adhesion but Not DNA Repair , 2012, PloS one.
[6] D. Radisky,et al. Growth of lung cancer cells in three-dimensional microenvironments reveals key features of tumor malignancy. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[7] Michael J. Thrall,et al. Human lung cancer cells grown on acellular rat lung matrix create perfusable tumor nodules. , 2012, The Annals of thoracic surgery.
[8] J. M. Wallis,et al. Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. , 2012, Tissue engineering. Part C, Methods.
[9] Satoru Miyano,et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. , 2012, Cancer research.
[10] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[11] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[12] Igor Jurisica,et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Christian Schuetz,et al. Regeneration and orthotopic transplantation of a bioartificial lung , 2010, Nature Medicine.
[14] G. Lajoie,et al. Matrigel: A complex protein mixture required for optimal growth of cell culture , 2010, Proteomics.
[15] W. V. van IJcken,et al. Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction , 2010, PloS one.
[16] Alexander Pertsemlidis,et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. , 2009, Genes & development.
[17] Keitaro Matsuo,et al. Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Dror Berel,et al. Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma , 2009, PloS one.
[19] Chris Sander,et al. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors , 2009, Oncogene.
[20] A Berghold,et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review , 2009, European Respiratory Journal.
[21] Martin M Matzuk,et al. A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. , 2008, RNA.
[22] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[23] F. Pampaloni,et al. The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.
[24] Jack A. M. Leunissen,et al. Turning CFCs into salt. , 1996, Nucleic Acids Res..
[25] I. Sipes,et al. Preparation and composition of alveolar extracellular matrix and incorporated basement membrane , 2007, Lung.
[26] C. Brosnan,et al. Interleukin-11 Potentiates Oligodendrocyte Survival and Maturation, and Myelin Formation , 2006, The Journal of Neuroscience.
[27] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[28] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[29] Robert M. Gemmill,et al. WNT7a induces E-cadherin in lung cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Haber,et al. DOCK4, a GTPase Activator, Is Disrupted during Tumorigenesis , 2003, Cell.
[32] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[33] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[34] Kenneth M. Yamada,et al. Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.
[35] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Knuechel,et al. Three-dimensional in vitro cocultivation of lung carcinoma cells with human bronchial organ culture as a model for bronchial carcinoma. , 1999, American journal of respiratory cell and molecular biology.
[37] H. Smeets,et al. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. , 1993, Science.
[38] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.